🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the present trial is: * to determine the dose limiting to...
Status
Withdrawn
Location
Gustave Roussy Institute,
Start Date
2012-06
Trial ID
NCT01764009
Treatments Being Tested
Cervix carcinoma has been a serious, long-term issue in the Czech Republic....
Status
Completed
Location
Aeskulab Patologie, ks
Start Date
2017-09-01
Trial ID
NCT05578833
Investigation of the mechanisms of persistent SARS-CoV-2 associated olfacto...
Status
Recruiting
Location
Cliniques Universitaires Saint-Luc
Start Date
2024-01-24
Trial ID
NCT06482138
Treatments Being Tested
We aim to analyze whether the "liquid biopsy" model could increase the spec...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04079699
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Withdrawn
Location
Multiple Locations
Start Date
2000-12
Trial ID
NCT00027521
Treatments Being Tested
Background: \- Researchers who study health and nutrition are interested i...
Status
Completed
Location
NIDDK, Phoenix
Start Date
2010-10-24
Trial ID
NCT01237093
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The study aims to evaluate the potential clinical impact of a highly sensit...
Status
Active Not Recruiting
Location
Hospital of West Jutland
Start Date
2019-11-01
Trial ID
NCT04100733
Treatments Being Tested
The purpose of this study is to find the number of natural killer (NK) cell...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2018-05-22
Trial ID
NCT02890758
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093